CWM
AZN icon

Chesapeake Wealth Management’s AstraZeneca AZN Stock Holding History

Chesapeake Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,015
Closed -$200K – 223
2021
Q1 		$200K Sell
2,015
-1,143
-36% -$115K 0.07% 218
2020
Q4 		$315K Sell
3,158
-2,616
-45% -$277K 0.11% 173
2020
Q3 		$633K Buy
5,774
+720
+14% +$80.1K 0.24% 100
2020
Q2 		$535K Buy
5,054
+2,110
+72% +$218K 0.21% 110
2020
Q1 		$263K Buy
+2,944
New +$277K 0.12% 153

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Chesapeake Wealth Management's AZN Position: Q2 2021 in Review

Chesapeake Wealth Management sold out of AstraZeneca (AZN) in Q2 2021, closing a stake of 2,015 shares — an estimated $200K sold.

Chesapeake Wealth Management first reported a position in AZN in Q1 2020 and held it in 5 quarters. The position peaked at $633K in Q3 2020. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

  • Chesapeake Wealth Management reported no remaining AstraZeneca position as of Q2 2021 after selling out during the quarter.
  • Chesapeake Wealth Management sold 2,015 AstraZeneca shares in Q2 2021, an estimated $200K.
  • Chesapeake Wealth Management first reported a position in AstraZeneca in Q1 2020 and held it in 5 quarters.
  • Chesapeake Wealth Management's AstraZeneca position peaked at $633K in Q3 2020.
  • 771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Chesapeake Wealth Management's 13F filing for Q2 2021, filed 29 Jul 2021.